MRMD (MariMed) Cyclically Adjusted Book per Share: $0.14 (As of Mar. 2026)


What is MariMed Cyclically Adjusted Book per Share?

MariMed MRMD Cyclically Adjusted Book per Share is $0.14 as of Mar. 2026. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

MariMed's adjusted book value per share for the three months ended in Mar. 2026 was $0.121. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.14 for the trailing ten years ended in Mar. 2026.

During the past 12 months, MariMed's average Cyclically Adjusted Book Growth Rate was 16.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 32.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of MariMed was 40.10% per year. The lowest was 32.60% per year. And the median was 36.35% per year.

As of today (2026-07-01), MariMed's current stock price is $0.0701. MariMed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $0.14. MariMed's Cyclically Adjusted PB Ratio of today is 0.50.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of MariMed was 25.25. The lowest was 0.48. And the median was 3.64.


MariMed  (OTCPK:MRMD) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

MariMed's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0701/0.14
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of MariMed was 25.25. The lowest was 0.48. And the median was 3.64.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


MariMed Cyclically Adjusted Book per Share Related Terms


MariMed Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for MariMed's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MariMed Cyclically Adjusted Book per Share Chart

MariMed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.06 0.09 0.11 0.14

MariMed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.13 0.13 0.14 0.14

MRMD vs RMTI, CPHI, TXMD: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MariMed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MariMed Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MariMed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where MariMed's Cyclically Adjusted PB Ratio falls into.



MariMed Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MariMed's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.121/330.2130*330.2130
=0.121

Current CPI (Mar. 2026) = 330.2130.

MariMed Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.029 241.018 -0.040
201609 -0.029 241.428 -0.040
201612 -0.017 241.432 -0.023
201703 0.003 243.801 0.004
201706 0.029 244.955 0.039
201709 0.044 246.819 0.059
201712 0.061 246.524 0.082
201803 0.059 249.554 0.078
201806 0.112 251.989 0.147
201809 0.180 252.439 0.235
201812 0.294 251.233 0.386
201903 0.310 254.202 0.403
201906 0.380 256.143 0.490
201909 0.376 256.759 0.484
201912 0.030 256.974 0.039
202003 -0.034 258.115 -0.043
202006 -0.014 257.797 -0.018
202009 0.002 260.280 0.003
202012 0.028 260.474 0.035
202103 0.047 264.877 0.059
202106 0.078 271.696 0.095
202109 0.111 274.310 0.134
202112 0.113 278.802 0.134
202203 0.135 287.504 0.155
202206 0.144 296.311 0.160
202209 0.157 296.808 0.175
202212 0.172 296.797 0.191
202303 0.192 301.836 0.210
202306 0.222 305.109 0.240
202309 0.217 307.789 0.233
202312 0.191 306.746 0.206
202403 0.188 312.332 0.199
202406 0.185 314.175 0.194
202409 0.183 315.301 0.192
202412 0.158 315.605 0.165
202503 0.157 319.799 0.162
202506 0.154 322.561 0.158
202509 0.142 324.800 0.144
202512 0.131 324.054 0.133
202603 0.121 330.213 0.121

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.14 mean?
MariMed (MRMD) has a Cyclically Adjusted Book per Share of $0.14 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on MariMed and its competitors.
Is MariMed's Cyclically Adjusted Book per Share too high?
MariMed's current Cyclically Adjusted Book per Share is $0.14.
How does MariMed's Cyclically Adjusted Book per Share compare to RMTI and CPHI?
MariMed's Cyclically Adjusted Book per Share of $0.14 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on MariMed and its competitors. MariMed's current Cyclically Adjusted Book per Share is $0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MariMed stock overvalued right now?
Based on GuruFocus' analysis, MariMed (MRMD) is currently considered Possible Value Trap. The stock's GF Value™ is $0.16, compared to a current price of $0.07 — trading 56.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is $0.14. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For MariMed (MRMD), the current Cyclically Adjusted Book per Share is $0.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MariMed Business Description

Other Exchanges MRMD:Canada
Address 10 Oceana Way, Floor 2, Norwood, MA, USA, 02062
MariMed Inc is a multi-state cannabis operator in the United States dedicated to improving lives every day through its high-quality products. The company develops, owns, and manages seed to sale state-licensed, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. It has created and continues to develop its own brands of cannabis flower, concentrates, edibles, and other precision-dosed products utilizing its proprietary strains and formulations. The company also licenses its proprietary brands, along with other top cannabis products, in select domestic markets. Its operations are conducted in compliance with applicable state and local laws and regulations in the jurisdictions in which it operates.